Martin Kunz serves as Executive at Twist Bioscience Corp, where they oversee executive responsibilities. Since joining the company, Martin Kunz has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 3, 2024 involved receiving (via award) 10,470 shares valued at $0.
Martin Kunz currently holds 22,402 shares of Twist Bioscience Corp (TWST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Kunz has been a net neutral trader of TWST stock. They have purchased $0 and sold $0 worth of shares.
Martin Kunz's most recent insider trade was on Jan 3, 2024, when they sold 10,470 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 24, 2019 | TWST | $0 | Award | 7,410 | $N/A | Discretionary |
| Feb 4, 2019 | TWST | $0 | Award | 12,936 | $N/A | Discretionary |